FLASH interacts with p160 coactivator subtypes and differentially suppresses transcriptional activity of steroid

Tomoshige Kino1, Takamasa Ichijo, George P Chrousos

  • 1Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, Building 10, Clinical Research Center, Room 1-3140 , 10 Center Drive, MSC 1109, Bethesda, MD 20892-1109, USA. kinot@mail.nih.gov

Insights

Tumor necrosis factor receptor-associated FLASH protein specifically inhibits steroid hormone receptor activity. It interferes with coactivators SRC2 and SRC3, but not SRC1, affecting gene transcription.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • Nuclear receptors (NRs) regulate gene expression, requiring coactivators for activity.
  • p160 family coactivators, including GRIP1 (SRC2), TRAM1 (SRC3), and SRC1, are crucial for NR function.
  • FLASH (Fas-associated death domain-like interleukin-1β-converting enzyme-associated protein) is a known inhibitor of glucocorticoid receptor (GR) activity.

Purpose of the Study:

  • To investigate the specificity of FLASH's inhibitory effect on nuclear receptor transcriptional activity.
  • To elucidate the physical and functional interactions between FLASH and different p160 coactivator subtypes (SRC1, SRC2, SRC3).

Main Methods:

  • Yeast two-hybrid assays to assess protein-protein interactions.
  • Reporter gene assays using the mouse mammary tumor virus (MMTV) promoter in cell lines (HCT116, HeLa).
  • Assessment of FLASH's effect on the transactivation activity of various steroid hormone receptors (GR, androgen receptor, progesterone receptor, estrogen receptor).

Main Results:

  • FLASH strongly interacted with the nuclear receptor-binding (NRB) domains of GRIP1 (SRC2) and TRAM1 (SRC3), but weakly with SRC1.
  • FLASH significantly suppressed GR, androgen receptor, and progesterone receptor transcriptional activity, mediated by SRC2 and SRC3.
  • FLASH did not inhibit estrogen receptor-mediated transactivation or transcription enhanced by SRC1.

Conclusions:

  • FLASH exhibits differential suppression of steroid hormone receptor activity based on coactivator usage.
  • FLASH specifically interferes with the recruitment of SRC2 and SRC3 coactivators, but not SRC1, to nuclear receptors.
  • This differential interaction mechanism highlights the specificity of FLASH as a regulator of nuclear receptor signaling.

Related Concept Videos

Intracellular Hormone Receptors01:08

Intracellular Hormone Receptors

Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
59.4K
Prokaryotic Transcriptional Activators and Repressors01:58

Prokaryotic Transcriptional Activators and Repressors

The organization of prokaryotic genes in their genome is notably different from that of eukaryotes. Prokaryotic genes are organized, such that the genes for proteins involved in the same biochemical process or function are located together in groups. This group of genes, along with their regulatory elements, are collectively known as an operon. The functional genes in an operon are transcribed together to give a single strand of mRNA known as polycistronic mRNA.
Transcription of prokaryotic...
25.5K
Types of Hormones02:13

Types of Hormones

Hormones can be classified into three main types based on their chemical structures: steroids, peptides, and amines. Their actions are mediated by the specific receptors they bind to on target cells.
83.7K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.8K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.0K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.8K